News
3d
TipRanks on MSNAstraZeneca’s Latest Study on AZD5004: A Potential Game-Changer for Liver Impairment Treatment?
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca is conducting a Phase I study titled ‘A Phase I, ...
After being on simvastatin for 25 years, my nurse switched me to a new ‘better’ statin, atorvastatin. But my liver function tests went through the roof: I started to go yellow, and was checked ...
Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment remains on track across programs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results